Among them, triple negative breast cancer (TNBC), negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2), is a special type [4]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.